Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 924

1.

Effect of additives on liquid droplets and aggregates of proteins.

Shiraki K, Mimura M, Nishinami S, Ura T.

Biophys Rev. 2020 Mar 12. doi: 10.1007/s12551-020-00682-9. [Epub ahead of print] Review.

2.

Favipiravir, an anti-influenza drug against life-threatening RNA virus infections.

Shiraki K, Daikoku T.

Pharmacol Ther. 2020 Feb 22:107512. doi: 10.1016/j.pharmthera.2020.107512. [Epub ahead of print] Review.

3.

Optical Fingerprints of Proteases and Their Inhibited Complexes Provided by Differential Cross-Reactivity of Fluorophore-Labeled Single-Stranded DNA.

Tomita S, Sugai H, Mimura M, Ishihara S, Shiraki K, Kurita R.

ACS Appl Mater Interfaces. 2019 Dec 18;11(50):47428-47436. doi: 10.1021/acsami.9b17829. Epub 2019 Dec 4.

PMID:
31747245
4.

Growth activation of influenza virus by trypsin and effect of T-705 (favipiravir) on trypsin-optimized growth condition.

Daikoku T, Okuda T, Kawai M, Morita N, Tanaka T, Takemoto M, Fukuda Y, Takahashi K, Nomura N, Shiraki K.

Acta Virol. 2019;63(3):309-315. doi: 10.4149/av_2019_311.

PMID:
31507197
5.

Salt-containing aqueous two-phase system shows predictable partition of proteins with surface amino acids residues.

Shibata C, Iwashita K, Shiraki K.

Int J Biol Macromol. 2019 Jul 15;133:1182-1186. doi: 10.1016/j.ijbiomac.2019.04.185. Epub 2019 May 2.

PMID:
31055113
6.

Selective separation method of aggregates from IgG solution by aqueous two-phase system.

Shibata C, Iwashita K, Shiraki K.

Protein Expr Purif. 2019 Sep;161:57-62. doi: 10.1016/j.pep.2019.05.002. Epub 2019 May 1.

PMID:
31054316
7.

Changing clinical and molecular characteristics of hepatitis E virus infection in Mie Prefecture, Japan: Disappearance of indigenous subtype 3e strains.

Nakano T, Okano H, Takahashi M, Nagashima S, Shiraki K, Oya Y, Inoue H, Ohmori S, Tsukimoto M, Ishida S, Fujimoto S, Kobayashi M, Yamawaki M, Kumagai M, Ninomiya J, Maegawa T, Kojima Y, Araki J, Hamaoka S, Horiike S, Yoshimura H, Takeuchi K, Itoh K, Akachi S, Uraki S, Yamamoto N, Ogura S, Sugimoto K, Yoshikawa K, Hasegawa H, Iwasa M, Takei Y, Okamoto H.

Hepatol Res. 2019 Sep;49(9):1003-1014. doi: 10.1111/hepr.13357. Epub 2019 Jun 7.

PMID:
31026368
8.

The binding affinity of uncharged aromatic solutes for negatively charged resins is enhanced by cations via cation-π interactions: The case of sodium ion and arginine.

Hirano A, Iwashita K, Ura T, Sakuraba S, Shiraki K, Arakawa T, Kameda T.

J Chromatogr A. 2019 Jun 21;1595:97-107. doi: 10.1016/j.chroma.2019.02.043. Epub 2019 Feb 21.

PMID:
30833023
9.

Effect of additives on liquid droplet of protein-polyelectrolyte complex for high-concentration formulations.

Mimura M, Tsumura K, Matsuda A, Akatsuka N, Shiraki K.

J Chem Phys. 2019 Feb 14;150(6):064903. doi: 10.1063/1.5063378.

PMID:
30769990
10.

Persistent Primary Cytomegalovirus Infection After Deceased Donor Kidney Transplant: Ganciclovir Susceptibility of Human Cytomegalovirus With UL97 D605E Mutation: A Case Report.

Nawashiro Y, Shiraki K, Yamamoto S, Takizawa K, Sasada Y, Suehiro M, Miura K, Hattori M, Daikoku T, Hisano M.

Transplant Proc. 2018 Dec;50(10):3932-3936. doi: 10.1016/j.transproceed.2018.09.010. Epub 2018 Sep 8.

PMID:
30577289
11.

Universal varicella vaccination reduced the incidence of herpes zoster in vaccine recipients 1 to 4 years of age.

Toyama N; Miyazaki Dermatologist Society, Shiraki K; Miyazaki Dermatologist Society.

J Dermatol Sci. 2018 Dec;92(3):284-286. doi: 10.1016/j.jdermsci.2018.11.001. Epub 2018 Nov 13. No abstract available.

PMID:
30551916
12.

Everolimus delayed and suppressed cytomegalovirus DNA synthesis, spread of the infection, and alleviated cytomegalovirus infection.

Tan L, Sato N, Shiraki A, Yanagita M, Yoshida Y, Takemura Y, Shiraki K.

Antiviral Res. 2019 Feb;162:30-38. doi: 10.1016/j.antiviral.2018.12.004. Epub 2018 Dec 10.

PMID:
30543830
13.

Control of Aggregation, Coaggregation, and Liquid Droplet of Proteins Using Small Additives.

Iwashita K, Mimura M, Shiraki K.

Curr Pharm Biotechnol. 2018;19(12):946-955. doi: 10.2174/1389201020666181204113054. Review.

PMID:
30514188
14.

Non-chromatographic purification of Teriparatide with a pH-responsive CspB tag.

Nonaka T, Tsurui N, Mannen T, Kikuchi Y, Shiraki K.

Protein Expr Purif. 2019 Mar;155:66-71. doi: 10.1016/j.pep.2018.11.008. Epub 2018 Nov 25.

PMID:
30485791
15.

Tofogliflozin Salt Cocrystals with Sodium Acetate and Potassium Acetate.

Takata N, Tanida S, Nakae S, Shiraki K, Tozuka Y, Ishigai M.

Chem Pharm Bull (Tokyo). 2018;66(11):1035-1040. doi: 10.1248/cpb.c18-00483.

16.

Coacervates and coaggregates: Liquid-liquid and liquid-solid phase transitions by native and unfolded protein complexes.

Iwashita K, Handa A, Shiraki K.

Int J Biol Macromol. 2018 Dec;120(Pt A):10-18. doi: 10.1016/j.ijbiomac.2018.08.063. Epub 2018 Aug 14.

PMID:
30114421
17.

Improvement of refractory acyclovir-resistant herpes simplex virus type 1 infection by continuous acyclovir administration.

Ikawa Y, Fujiki T, Nishimura R, Noguchi K, Koshino E, Fujiki A, Fukuda M, Kuroda R, Mase S, Araki R, Maeba H, Shiraki K, Yachie A.

J Infect Chemother. 2019 Jan;25(1):65-67. doi: 10.1016/j.jiac.2018.07.004. Epub 2018 Jul 29.

PMID:
30064949
18.

Universal varicella vaccination increased the incidence of herpes zoster in the child-rearing generation as its short-term effect.

Toyama N, Shiraki K; Miyazaki Dermatologist Society.

J Dermatol Sci. 2018 Oct;92(1):89-96. doi: 10.1016/j.jdermsci.2018.07.003. Epub 2018 Jul 10.

PMID:
30041832
19.

Second-line triple therapy in failures with vonoprazan-based triple therapy for eradication of Helicobacter pylori.

Mori N, Nishiura Y, Suga D, Moritani I, Yamanaka Y, Ooya Y, Inoue H, Takase K, Hioki M, Shiraki K.

Biomed Rep. 2018 Aug;9(2):169-174. doi: 10.3892/br.2018.1111. Epub 2018 Jun 11.

20.

Effects of allantoin and dimethyl sulfoxide on the thermal aggregation of lysozyme.

Nishinami S, Hirano A, Arakawa T, Shiraki K.

Int J Biol Macromol. 2018 Nov;119:180-185. doi: 10.1016/j.ijbiomac.2018.07.043. Epub 2018 Jul 26.

PMID:
30009897
21.

Arginine suppresses opalescence and liquid-liquid phase separation in IgG solutions.

Oki S, Nishinami S, Shiraki K.

Int J Biol Macromol. 2018 Oct 15;118(Pt B):1708-1712. doi: 10.1016/j.ijbiomac.2018.07.010. Epub 2018 Jul 5.

PMID:
29981328
22.

Liquid Droplet of Protein-Polyelectrolyte Complex for High-Concentration Formulations.

Matsuda A, Mimura M, Maruyama T, Kurinomaru T, Shiuhei M, Shiraki K.

J Pharm Sci. 2018 Oct;107(10):2713-2719. doi: 10.1016/j.xphs.2018.06.021. Epub 2018 Jun 27.

PMID:
29960025
23.

Antiviral Drugs Against Alphaherpesvirus.

Shiraki K.

Adv Exp Med Biol. 2018;1045:103-122. doi: 10.1007/978-981-10-7230-7_6. Review.

PMID:
29896665
24.

Array-based Generation of Response Patterns with Common Fluorescent Dyes for Identification of Proteins and Cells.

Mimura M, Tomita S, Kurita R, Shiraki K.

Anal Sci. 2019 Jan 10;35(1):99-102. doi: 10.2116/analsci.18SDN01. Epub 2018 May 25.

25.

Salt-dependent elution of uncharged aromatic solutes in ion-exchange chromatography.

Hirano A, Iwashita K, Sakuraba S, Shiraki K, Arakawa T, Kameda T.

J Chromatogr A. 2018 Apr 20;1546:46-55. doi: 10.1016/j.chroma.2018.02.049. Epub 2018 Mar 6.

PMID:
29551239
26.

Allantoin and hydantoin as new protein aggregation suppressors.

Nishinami S, Yoshizawa S, Arakawa T, Shiraki K.

Int J Biol Macromol. 2018 Jul 15;114:497-503. doi: 10.1016/j.ijbiomac.2018.03.011. Epub 2018 Mar 2.

PMID:
29505874
27.

EFFICACY AND SAFETY OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOCUSING ON PATIENTS WITH DIABETIC MACULAR EDEMA FROM JAPAN.

Terasaki H, Shiraki K, Ohji M, Metzig C, Schmelter T, Zeitz O, Sowade O, Kobayashi M, Vitti R, Berliner A, Shiraga F.

Retina. 2019 May;39(5):938-947. doi: 10.1097/IAE.0000000000002100.

28.

Helicase-primase inhibitor amenamevir for herpesvirus infection: Towards practical application for treating herpes zoster.

Shiraki K.

Drugs Today (Barc). 2017 Nov;53(11):573-584. doi: 10.1358/dot.2017.53.11.2724803. Review.

PMID:
29451274
29.

A new pH-responsive peptide tag for protein purification.

Nonaka T, Tsurui N, Mannen T, Kikuchi Y, Shiraki K.

Protein Expr Purif. 2018 Jun;146:91-96. doi: 10.1016/j.pep.2018.02.004. Epub 2018 Feb 10.

PMID:
29432812
30.

Specific solubilization of impurities in culture media: Arg solution improves purification of pH-responsive tag CspB50 with Teriparatide.

Oki S, Nonaka T, Shiraki K.

Protein Expr Purif. 2018 Jun;146:85-90. doi: 10.1016/j.pep.2018.02.001. Epub 2018 Feb 6.

PMID:
29425938
31.

Age-dependent trigeminal and female-specific lumbosacral increase in herpes zoster distribution in the elderly.

Shiraki K, Toyama N, Shiraki A, Yajima M; Miyazaki Dermatologist Society.

J Dermatol Sci. 2018 May;90(2):166-171. doi: 10.1016/j.jdermsci.2018.01.009. Epub 2018 Jan 31.

PMID:
29395575
32.

Corrigendum to "Mechanism of protein desorption from 4-mercaptoethylpyridine resins by arginine solutions" [J. Chromatogr. A 1373 (2014) 141-148].

Hirano A, Maruyama T, Shiraki K, Arakawa T, Kameda T.

J Chromatogr A. 2018 Jan 12;1532:257-258. doi: 10.1016/j.chroma.2017.12.027. Epub 2017 Dec 13. No abstract available.

PMID:
29248343
33.

Viscosity Control of Protein Solution by Small Solutes: A Review.

Hong T, Iwashita K, Shiraki K.

Curr Protein Pept Sci. 2018;19(8):746-758. doi: 10.2174/1389203719666171213114919. Review.

34.

Two Elution Mechanisms of MEP Chromatography.

Arakawa T, Tokunaga M, Maruyama T, Shiraki K.

Curr Protein Pept Sci. 2019;20(1):28-33. doi: 10.2174/1389203718666171117105132. Review.

PMID:
29150920
35.

Hepatitis E virus subtype 3f strains isolated from Japanese hepatitis patients with no history of travel to endemic areas - The origin analyzed by molecular evolution.

Nakano T, Takahashi M, Takahashi K, Nagashima S, Suzuki Y, Nishigaki Y, Tomita E, Okano H, Oya Y, Shiraki K, Takase K, Sugimoto K, Koyama J, Mizuo H, Ikezawa K, Aikawa T, Arai M, Okamoto H.

Virology. 2018 Jan 1;513:146-152. doi: 10.1016/j.virol.2017.08.008. Epub 2017 Oct 24.

36.

Effects of Arginine on Multimodal Chromatography: Experiments and Simulations.

Hirano A, Shiraki K, Kameda T.

Curr Protein Pept Sci. 2019;20(1):40-48. doi: 10.2174/1389203718666171024115407. Review.

PMID:
29065827
37.

Mechanism of co-aggregation in a protein mixture with small additives.

Oki S, Iwashita K, Kimura M, Kano H, Shiraki K.

Int J Biol Macromol. 2018 Feb;107(Pt B):1428-1437. doi: 10.1016/j.ijbiomac.2017.10.004. Epub 2017 Oct 5.

PMID:
28988840
38.

Trimethylamine N-oxide (TMAO) is a counteracting solute of benzyl alcohol for multi-dose formulation of immunoglobulin.

Yoshizawa S, Oki S, Arakawa T, Shiraki K.

Int J Biol Macromol. 2018 Feb;107(Pt A):984-989. doi: 10.1016/j.ijbiomac.2017.09.072. Epub 2017 Sep 20.

PMID:
28939518
39.

Influence of Acquisition Mode of Cone-beam Computed Tomography on Accuracy of Image Registration for Image-guided Radiotherapy.

Taniguchi T, Hara T, Shimozato T, Shiraki K, Ohono K, Maejima R.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2017;73(8):646-653. doi: 10.6009/jjrt.2017_JSRT_73.8.646. Japanese.

40.

Characterization of susceptibility variants of poliovirus grown in the presence of favipiravir.

Daikoku T, Mizuguchi M, Obita T, Yokoyama T, Yoshida Y, Takemoto M, Shiraki K.

J Microbiol Immunol Infect. 2018 Oct;51(5):581-586. doi: 10.1016/j.jmii.2017.03.004. Epub 2017 Jun 29.

41.

One-Step Identification of Antibody Degradation Pathways Using Fluorescence Signatures Generated by Cross-Reactive DNA-Based Arrays.

Tomita S, Matsuda A, Nishinami S, Kurita R, Shiraki K.

Anal Chem. 2017 Aug 1;89(15):7818-7822. doi: 10.1021/acs.analchem.7b01264. Epub 2017 Jul 18.

PMID:
28707471
42.

Noncovalent PEGylation through Protein-Polyelectrolyte Interaction: Kinetic Experiment and Molecular Dynamics Simulation.

Kurinomaru T, Kuwada K, Tomita S, Kameda T, Shiraki K.

J Phys Chem B. 2017 Jul 20;121(28):6785-6791. doi: 10.1021/acs.jpcb.7b02741. Epub 2017 Jul 11.

PMID:
28650657
43.
44.

Thermal aggregation of human immunoglobulin G in arginine solutions: Contrasting effects of stabilizers and destabilizers.

Yoshizawa S, Arakawa T, Shiraki K.

Int J Biol Macromol. 2017 Nov;104(Pt A):650-655. doi: 10.1016/j.ijbiomac.2017.06.085. Epub 2017 Jun 21.

PMID:
28647523
45.

Nutritional correlates of monetary diet cost in young, middle-aged and older Japanese women.

Shiraki K, Murakami K, Okubo H, Livingstone MBE, Kobayashi S, Suga H, Sasaki S; Three-Generation Study of Women on Diets and Health Study Group.

J Nutr Sci. 2017 May 22;6:e22. doi: 10.1017/jns.2017.18. eCollection 2017.

46.

Interaction of Immunoglobulin with Cytomegalovirus-Infected Cells.

Aiba N, Shiraki A, Yajima M, Oyama Y, Yoshida Y, Ohno A, Yamada H, Takemoto M, Daikoku T, Shiraki K.

Viral Immunol. 2017 Sep;30(7):500-507. doi: 10.1089/vim.2016.0151. Epub 2017 Jun 9.

47.

Arginine prevents thermal aggregation of hen egg white proteins.

Hong T, Iwashita K, Handa A, Shiraki K.

Food Res Int. 2017 Jul;97:272-279. doi: 10.1016/j.foodres.2017.04.013. Epub 2017 Apr 19.

PMID:
28578052
48.

Herpes Zoster and Recurrent Herpes Zoster.

Shiraki K, Toyama N, Daikoku T, Yajima M; Miyazaki Dermatologist Society.

Open Forum Infect Dis. 2017 Jan 28;4(1):ofx007. doi: 10.1093/ofid/ofx007. eCollection 2017 Winter.

49.

Effects of wet-granulation process parameters on the dissolution and physical stability of a solid dispersion.

Kinoshita R, Ohta T, Shiraki K, Higashi K, Moribe K.

Int J Pharm. 2017 May 30;524(1-2):304-311. doi: 10.1016/j.ijpharm.2017.04.007. Epub 2017 Apr 5.

PMID:
28389363
50.

Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletion.

Akahoshi Y, Kanda J, Ohno A, Komiya Y, Gomyo A, Hayakawa J, Harada N, Kameda K, Ugai T, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako-Saito K, Kimura SI, Kikuchi M, Nakasone H, Kako S, Shiraki K, Kanda Y.

J Infect Chemother. 2017 Jul;23(7):485-487. doi: 10.1016/j.jiac.2017.02.001. Epub 2017 Mar 2.

PMID:
28262533

Supplemental Content

Loading ...
Support Center